State Street Corp. Updates Passive Stake in Vanda Pharma
Ticker: VNDA · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 1347178
| Field | Detail |
|---|---|
| Company | Vanda Pharmaceuticals Inc. (VNDA) |
| Form Type | SC 13G/A |
| Filed Date | Jan 22, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**State Street Corp. still owns Vanda Pharma shares, no big changes.**
AI Summary
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 22, 2024, indicating its ownership of Vanda Pharmaceuticals Inc. common stock as of December 31, 2023. This filing is an update to their previous disclosures, confirming their continued passive investment in Vanda Pharmaceuticals. For investors, this means a significant institutional holder maintains its position, which can be a sign of confidence, but it doesn't signal any new aggressive moves or changes in company control.
Why It Matters
This filing confirms State Street Corporation's continued passive investment in Vanda Pharmaceuticals, providing transparency on institutional ownership without indicating any intent to influence company management.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not signal any immediate risks or opportunities for Vanda Pharmaceuticals.
Analyst Insight
An investor should note that State Street Corporation is a passive institutional holder, meaning this filing doesn't suggest any impending changes in Vanda Pharmaceuticals' management or strategic direction. It's a routine disclosure of continued ownership.
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- Vanda Pharmaceuticals Inc. (company) — the subject company whose stock is owned
- December 31, 2023 (date) — the date of the event requiring the filing
- January 22, 2024 (date) — the filing date of the SC 13G/A
- 0001347178 (number) — Central Index Key (CIK) for Vanda Pharmaceuticals Inc.
- 0000093751 (number) — Central Index Key (CIK) for State Street Corporation
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' section and the title 'SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 EXIT FILING'.
Who is the reporting person in this filing?
The reporting person is STATE STREET CORPORATION, as explicitly stated under '1. NAME OF REPORTING PERSON: STATE STREET CORPORATION'.
What is the subject company whose securities are being reported?
The subject company is VANDA PHARMACEUTICALS INC, as indicated under 'VANDA PHARMACEUTICALS INC (NAME OF ISSUER)'.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the common stock of Vanda Pharmaceuticals Inc. is 921659108, as listed under 'CUSIP NUMBER: 921659108'.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified under '12/31/2023 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding Vanda Pharmaceuticals Inc. (VNDA).